GGrantIndex
Sort

23,748 grants matching melanoma

Molecular Analysis Of Human Hereditary Deafness

$1,276,299
Andrew J. Griffith · National Institute On Deafness And Other Communication Disorders · ZIA · FY2015 · DC

Modification of hyperthermia response

$1,274,540
Thomas Jefferson University · P01 · FY2003 · CA

HUMAN MELANOMA--ETIOLOGY, PROGRESSION AND THERAPY

$1,271,012
Wistar Institute · P01 · FY2000 · CA

TUMOR SUPPRESSORS INVOLVED IN MULTIPLE TUMOR TYPES

$1,269,503
Columbia University Health Sciences · P01 · FY2000 · CA

DEFINING CHRONIC IMMUNE-RELATED ADVERSE EVENTS IN MELANOMA SURVIVORS

$1,267,303
Vanderbilt University Medical Center · · FY2025 · Defense Health Agency

NHGRI/DIR Technology Transfer Program

$1,265,189
Claire Driscoll · National Human Genome Research Institute · ZIK · FY2016 · HG

Cell Production Core Facility

$1,264,987
Robert Somerville · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA

Surgery Branch Cell Prep Core

$1,264,987
John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA

University of New Mexico Cancer Center Support

$1,264,145
Cheryl L Willman · University Of New Mexico · P30 · FY2009 · CA

Cachexia-mediated FcRn Modulation and Its Impact on Anti-PD1 Therapy in Lung Cancer

$1,263,739
Mitch A Phelps · Ohio State University · R01 · FY2025 · CA

Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1

$1,263,691
Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

NHGRI/DIR Technology Transfer Program

$1,261,312
Eric Green · National Human Genome Research Institute · ZIK · FY2010 · HG

Improving extraction success of FFPE samples with automated and reliable microfluidic sample preparation

$1,261,092
Jay Kenneth Fisher · Redbud Labs, Inc. · R44 · FY2025 · GM

Mutational analysis of signal transducing gene families in malignant melanoma

$1,258,953
Yardena Samuels · National Human Genome Research Institute · Z01 · FY2008 · HG

MELANOMA CHEMOPREVENTION VIA NEUROPILIN-2 AXIS BLOCKADE

$1,258,719
Children'S Hospital Corporation, The · · FY2024 · Defense Health Agency

Molecular Pathology Research for Cancer Diagnostics and Biomarkers

$1,258,277
Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma

$1,258,062
Geoffrey L Chupp · Yale University · UH3 · FY2016 · HL

SPORE in Skin Cancer

$1,256,837
Wistar Institute · P50 · FY2001 · CA

Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies

$1,253,006
Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2022 · CA

Defining the T-cell Response to Human Renal Cancer

$1,252,404
James C Yang · Clinical Sciences · Z01 · FY2007 · CA

Immunophysiological Mechanisms in the Biological Therapy of Cancer

$1,252,261
Robert Wiltrout · Basic Sciences · Z01 · FY2007 · CA

Preservation of Proteomic Stability and Promotion of Protein Lipidation by HSF1

$1,250,825
Chengkai Dai · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Regulation of epithelial cell fate decisions in tissue homeostasis and cancer

$1,250,210
Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

GENETIC APPROACHES FOR CANCER IMMUNOTHERAPY

$1,248,539
University Of Michigan At Ann Arbor · P01 · FY2000 · CA

Mechanobiology

$1,247,864
Alexander Cartagena-Rivera · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2020 · EB